IOL Chemicals and Pharmaceuticals Limited is engaged in manufacturing and selling of pharmaceutical and chemical products. The Company operates through two segments: Chemical and Pharmaceutical. The Chemical segment produces and sells Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride, Mono Chloro Acetic Acid, Para Amino Phenol (PAP), and others. The Pharmaceutical segment produces and sells various active pharma ingredients (API) including Ibuprofen, Metformin, Fenofibrate, Lamotrigine, Clopidogrel Bisulphate, Pantoprazole, Gabapentin, Paracetamol, and others. Its API product portfolio includes Pantoprazole Sodium, Clopidogrel Bisulphate (Form II), Losartan Potassium, Levetiracetam, and Fenofibrate (Micronised). Its Specialty Chemical division includes Ethyl Acetate, Iso Butyl Benzene, Mono Chloro acetic Acid, and Acetic Anhydride. Its Ethyl Acetate is used in industries like flexible packaging, pharmaceuticals, ink, food processing, pesticides, and the paint industry.As of 25 May 2026, IOL Chemicals and Pharmaceuticals share price is ₹124.00. The stock opened at ₹119.21, compared to its previous close of ₹118.73. During today's trading session, IOL Chemicals and Pharmaceuticals share price moved in the range of ₹119.21 to ₹126.00, with an average price of ₹122.60 for the day. Looking at its last 52-week, the stock has touched a low of ₹119.21 and a high of ₹126.00.
The market capitalization of IOL Chemicals and Pharmaceuticals is ₹3,487 Crs, with a P/E ratio of 25.3 and a dividend yield of 0.84%.